BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21059303)

  • 1. [Effect of peginterferon alpha-2a combinated with ribavirin in the treatment of rebound patient with chronic hepatitis C: a case report].
    He Q; Li ZY
    Zhonghua Gan Zang Bing Za Zhi; 2010 Oct; 18(10):794. PubMed ID: 21059303
    [No Abstract]   [Full Text] [Related]  

  • 2. Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients.
    Zeuzem S
    J Hepatol; 2008 Aug; 49(2):157-9. PubMed ID: 18554745
    [No Abstract]   [Full Text] [Related]  

  • 3. [Peginterferon alpha-2a and ribavirin for treating chronic hepatitis C patients with persistent normal aminotransferase levels].
    Jiang TJ; Fan R; Xie YX; Zhao P; Zhang X; Zhao M; Zhou ZP; He J
    Zhonghua Gan Zang Bing Za Zhi; 2008 Apr; 16(4):307-8. PubMed ID: 18423159
    [No Abstract]   [Full Text] [Related]  

  • 4. Spotlight on peginterferon-alpha-2a (40 kD) plus ribavirin in the management of chronic hepatitis C mono-infection.
    Keam SJ; Cvetković RS
    BioDrugs; 2009; 23(1):63-8. PubMed ID: 19344193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retreatment with peginterferon alpha-2a plus ribavirin for chronic hepatitis C: a case report].
    Zhang YH
    Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):315. PubMed ID: 21805745
    [No Abstract]   [Full Text] [Related]  

  • 6. Peginterferon and ribavirin for hepatitis C.
    Abramowicz M
    N Engl J Med; 2007 Mar; 356(12):1270-1; author reply 1271. PubMed ID: 17378100
    [No Abstract]   [Full Text] [Related]  

  • 7. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C.
    Rakov NE
    N Engl J Med; 2003 Jan; 348(3):259-60; author reply 259-60. PubMed ID: 12529472
    [No Abstract]   [Full Text] [Related]  

  • 8. Peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a monotherapy in early virological responders and peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a, ribavirin and amantadine triple therapy in early virological nonresponders: the SMIEC II trial in naïve patients with chronic hepatitis C.
    Angelico M; Koehler-Horst B; Piccolo P; Angelico F; Gentile S; Francioso S; Tarquini P; Vecchia RD; Ponti L; Pilleri G; Barlattani A; Grieco A; Soccorsi F; Guarascio P; Demelia L; Sorbello O; Rossi Z; Forlini G; Zaru S; Bandiera F;
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):680-7. PubMed ID: 18679072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
    Jung YK; Kim JH
    Clin Mol Hepatol; 2013 Mar; 19(1):26-8. PubMed ID: 23593606
    [No Abstract]   [Full Text] [Related]  

  • 10. Peginterferon and ribavirin for chronic hepatitis C.
    Hoofnagle JH; Seeff LB
    N Engl J Med; 2006 Dec; 355(23):2444-51. PubMed ID: 17151366
    [No Abstract]   [Full Text] [Related]  

  • 11. Peginterferon and ribavirin for hepatitis C.
    Duggan AE; Duggan JM
    N Engl J Med; 2007 Mar; 356(12):1269; author reply 1271. PubMed ID: 17377169
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of efficacy of peginterferon and ribavirin combination therapy for chronic hepatitis C among Korean, Caucasian and other Asians].
    Kim KA
    Korean J Gastroenterol; 2012 Nov; 60(5):273-4. PubMed ID: 23311002
    [No Abstract]   [Full Text] [Related]  

  • 13. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
    Fried MW; Shiffman ML; Reddy KR; Smith C; Marinos G; Gonçales FL; Häussinger D; Diago M; Carosi G; Dhumeaux D; Craxi A; Lin A; Hoffman J; Yu J
    N Engl J Med; 2002 Sep; 347(13):975-82. PubMed ID: 12324553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pegylated interferon α-2a and ribavirin antiviral therapy efficacy for treating chronic hepatitis C and its effects on psychological status of patients].
    An J; Qiao J; Ni W
    Zhonghua Gan Zang Bing Za Zhi; 2014 Oct; 22(10):772-3. PubMed ID: 25558497
    [No Abstract]   [Full Text] [Related]  

  • 15. Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.
    Taylor LE; Rich JD; Tashima KT
    N Engl J Med; 2004 Nov; 351(22):2340-2; author reply 2340-2. PubMed ID: 15564553
    [No Abstract]   [Full Text] [Related]  

  • 16. [A 72 week follow-up study of chronic hepatitis C patients treated with peginterferon alfa-2b and ribavirin].
    Yu SL; Zhang ZH; Lv H; Zhang QG; Wang YZ
    Zhonghua Gan Zang Bing Za Zhi; 2007 Mar; 15(3):231. PubMed ID: 17407724
    [No Abstract]   [Full Text] [Related]  

  • 17. Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.
    Gholam PM
    N Engl J Med; 2004 Nov; 351(22):2340-2; author reply 2340-2. PubMed ID: 15570682
    [No Abstract]   [Full Text] [Related]  

  • 18. [Peginterferon alpha combined with ribavirin for the treatment of chronic hepatitis C].
    Xu Y; Wang JB
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):415-6. PubMed ID: 22053369
    [No Abstract]   [Full Text] [Related]  

  • 19. Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in patients with chronic hepatitis C, using viral and host factors: some concerns.
    Dai CY; Chuang WL; Huang JF; Hsieh MY; Yu ML
    Hepatology; 2009 Jun; 49(6):2125; author reply 2125-6. PubMed ID: 19479790
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of chronic hepatitis C virus infection with peginterferon alpha-2a and ribavirin in patients with sickle cell disease.
    Ayyub MA; El-Moursy SA; Khazindar AM; Abbas FA
    Saudi Med J; 2009 May; 30(5):712-6. PubMed ID: 19417977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.